
Faced with recessionary pressures, ageing populations, and increasingly expensive therapies, governments are redoubling their efforts to contain healthcare costs. Biologics …
Scots neonatal innovations target hearing loss and earlier care
Long-acting therapies set to reshape HIV treatment market

